Science Explorer Interactive view Map
Company · Dallas · United States

Gradalis (United States)

gradalisinc.comROR OpenAlex
Research works
47
▲ 143% vs 2013–17
Citations
1.6k
33.2 per fractional work
Top-10% rate
22.4%
record average 16.5%
Open access
68%
world 28%

Not ranked overall: Gradalis (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.53× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.66× its world share, 0 worksImmunology and Micro…Engineering: 0.36× its world share, 0 worksEngineeringPhysics and Astronomy: 0.81× its world share, 0 worksPhysics and AstronomyMedicine: 3.30× its world share, 6 worksMedicineEconomics, Econometrics and Finance: 1.68× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.7×. Every wedge is a field page.

Which keywords describe research at Gradalis (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, Tumor Regression, Tumor Microenvironment, Cancer Immunotherapy, Tumor Targeting, Gene Silencing and RNA Interference.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy8▲ 61×3 topics
  2. Immunotherapy6▲ 18×9 topics
  3. Tumor Regression4▲ 110×2 topics
  4. Tumor Microenvironment4▲ 24×7 topics
  5. Cancer Immunotherapy4▲ 56×3 topics
  6. Gene Silencing3▲ 57×2 topics
  7. Tumor Targeting3▲ 52×3 topics
  8. RNA Interference3▲ 59×1 topic
  9. siRNA Delivery3▲ 89×1 topic
  10. Cancer3▲ 4.4×14 topics
  11. Metastasis3▲ 18×6 topics
  12. Arginine Deprivation3▲ 136×1 topic
  13. Bacterial Therapy3▲ 136×1 topic
  14. Cancer Therapy3▲ 8.6×10 topics
  15. Biomarkers2▲ 8.5×4 topics
  16. Immune Checkpoint Blockade2▲ 97×1 topic
  17. Immunity2▲ 15×4 topics
  18. Nanoparticles2▲ 4.0×3 topics
  19. PD-1 and PD-L12▲ 97×1 topic
  20. Chemotherapy2▲ 7.0×7 topics
  21. DNA nanotechnology2▲ 42×1 topic
  22. Self-Assembly2▲ 11×1 topic
  23. Innate Immunity2▲ 12×2 topics
  24. Lymphoma2▲ 28×2 topics
  25. Antigen Presentation2▲ 37×1 topic
  26. Cancer Progression2▲ 17×4 topics
  27. Clinical Trials2▲ 6.2×4 topics
  28. Dendritic Cells2▲ 33×1 topic
  29. CAR T Cells2▲ 84×1 topic
  30. Cancer Risk2▲ 14×4 topics
  31. Chimeric Antigen Receptor2▲ 84×1 topic
  32. Genomic Instability2▲ 28×3 topics
  33. Ovarian Cancer2▲ 40×2 topics
  34. Targeted Therapy2▲ 17×3 topics
  35. AAV2▲ 54×1 topic
  36. Cell Death2▲ 17×3 topics
  37. Homologous Recombination2▲ 50×2 topics
  38. Viral Vectors2▲ 54×1 topic
  39. Air Force2▲ 54×1 topic
  40. Islam2▲ 24×1 topic

Which research topics does Gradalis (United States) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, CAR-T cell therapy research and PARP inhibition in cancer therapy.

Cancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksCancer Genomics and Diagnostics: 1 fractional worksCAR-T cell therapy research: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksGenetic factors in color…0Genetic factors in colorectal cancer: 0 fractional worksOvarian cancer diagnosis and treatment: 0 fractional worksUterine Myomas and Treatments: 0 fractional worksAdenosine and Purinergic Signaling: 0 fractional worksCancer Cells and Metastasis: 0 fractional works
OncologyCancer ResearchImmunologyPathology and Forensic Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
  2. 2 Cancer Genomics and Diagnostics Cancer Research 1 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 PARP inhibition in cancer therapy Oncology 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  7. 7 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  8. 8 Uterine Myomas and Treatments Obstetrics and Gynecology 0 works
  9. 9 Adenosine and Purinergic Signaling Physiology 0 works
  10. 10 Cancer Cells and Metastasis Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.3%not open31.7%

World: 28% of research is openly available.

with international co-authors9.6%domestic only90.4%

World: 19% is written across borders.

How has Gradalis (United States)'s research output changed?

Output in 2018–2022 was 143% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Dallas

All research institutions in Dallas

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.